These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23227348)

  • 1. Treatment of neuroendocrine tumor liver metastases.
    Lewis MA; Hobday TJ
    Int J Hepatol; 2012; 2012():973946. PubMed ID: 23227348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal liver-directed management of neuroendocrine hepatic metastases.
    Lewis MA; Hubbard J
    Int J Hepatol; 2011; 2011():452343. PubMed ID: 22121491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery, Liver Directed Therapy and Peptide Receptor Radionuclide Therapy for Pancreatic Neuroendocrine Tumor Liver Metastases.
    Ngongoni R; Visser B
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic arterial embolization versus chemoembolization in the treatment of liver metastases from well-differentiated midgut endocrine tumors: a prospective randomized study.
    Maire F; Lombard-Bohas C; O'Toole D; Vullierme MP; Rebours V; Couvelard A; Pelletier AL; Zappa M; Pilleul F; Hentic O; Hammel P; Ruszniewski P
    Neuroendocrinology; 2012; 96(4):294-300. PubMed ID: 22507901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-arterial liver-directed therapies for neuroendocrine hepatic metastases.
    Gupta S
    Semin Intervent Radiol; 2013 Mar; 30(1):28-38. PubMed ID: 24436515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.
    Ito T; Lee L; Jensen RT
    Expert Opin Pharmacother; 2016 Nov; 17(16):2191-2205. PubMed ID: 27635672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical treatment of liver metastases in patients with neuroendocrine tumors.
    Saeed A; Buell JF; Kandil E
    Ann Transl Med; 2013 Apr; 1(1):6. PubMed ID: 25332951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review.
    Harring TR; Nguyen NT; Goss JA; O'Mahony CA
    Int J Hepatol; 2011; 2011():154541. PubMed ID: 22013537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Landmark Series: Neuroendocrine Tumor Liver Metastases.
    Gangi A; Howe JR
    Ann Surg Oncol; 2020 Sep; 27(9):3270-3280. PubMed ID: 32632880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic neuroendocrine metastases: chemo- or bland embolization?
    Pitt SC; Knuth J; Keily JM; McDermott JC; Weber SM; Chen H; Rilling WS; Quebbeman EJ; Agarwal DM; Pitt HA
    J Gastrointest Surg; 2008 Nov; 12(11):1951-60. PubMed ID: 18709512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of transarterial liver-directed therapies for low-grade metastatic neuroendocrine tumors in a single institution.
    Engelman ES; Leon-Ferre R; Naraev BG; Sharma N; Sun S; O'Dorisio TM; Howe J; Button A; Zamba G; Halfdanarson TR
    Pancreas; 2014 Mar; 43(2):219-25. PubMed ID: 24518499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver-directed therapies in liver metastases from neuroendocrine tumors of the gastrointestinal tract.
    Zappa M; Abdel-Rehim M; Hentic O; Vullierme MP; Ruszniewski P; Vilgrain V
    Target Oncol; 2012 Jun; 7(2):107-16. PubMed ID: 22707276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver-Directed Therapy for Neuroendocrine Tumor Liver Metastases in the Era of Peptide Receptor Radionuclide Therapy.
    Lehrman ED; Fidelman N
    Semin Intervent Radiol; 2020 Dec; 37(5):499-507. PubMed ID: 33328706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
    Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
    Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventional Liver-Directed Therapy for Neuroendocrine Metastases: Current Status and Future Directions.
    D'Souza D; Golzarian J; Young S
    Curr Treat Options Oncol; 2020 May; 21(6):52. PubMed ID: 32447461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of patients with hepatic metastases from neuroendocrine tumors.
    Clift AK; Frilling A
    Ann Saudi Med; 2014; 34(4):279-90. PubMed ID: 25811199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Effective Are Percutaneous Liver-Directed Therapies in Patients with Non-Colorectal Liver Metastases?
    Vogl TJ; Emam A; Naguib NN; Eichler K; Zangos S
    Viszeralmedizin; 2015 Dec; 31(6):406-13. PubMed ID: 26889144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic arterial embolization and chemoembolization in the management of patients with large-volume liver metastases.
    Kamat PP; Gupta S; Ensor JE; Murthy R; Ahrar K; Madoff DC; Wallace MJ; Hicks ME
    Cardiovasc Intervent Radiol; 2008; 31(2):299-307. PubMed ID: 17922160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic neuroendocrine metastases: does intervention alter outcomes?
    Chamberlain RS; Canes D; Brown KT; Saltz L; Jarnagin W; Fong Y; Blumgart LH
    J Am Coll Surg; 2000 Apr; 190(4):432-45. PubMed ID: 10757381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arterial Therapies of Non-Colorectal Liver Metastases.
    Puippe G; Pfammatter T; Schaefer N
    Viszeralmedizin; 2015 Dec; 31(6):414-22. PubMed ID: 26889145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.